Beta Drugs Limited

NSE: BETA

3

total announcements

BETA.NS · 15 min delayed

NSEStatement of deviation(s) or variation(s) under Reg. 32Regulatory1d ago

Beta Drugs Limited

Statement of deviation(s) or variation(s) under Reg. 32

Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming no deviation or variation in the use of proceeds from the objects stated in the Private Placement Offer cum Application Letter dated November 18, 2024.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults1d ago

Beta Drugs Limited

Outcome of Board Meeting

Beta Drugs Limited has announced its Q1FY27 results, with a 25.3% increase in consolidated total sales to Rs 125.55 crores and a 40.92% growth in net profit to Rs 16.5 crores.

Read more →📎 1 attachment